Engitix has inked an R&D deal focused on fibrosis and liver tumors with new investor Dompé Farmaceutici S.p.A. that it hopes will facilitate the UK biotech’s transition from a technology platform t
Financings The first quarter of 2012 featured $3.7 billion in biopharma financing, $1 billion more than Q4 2011’s total, but on pace with the opening quarter of last year, in which $3.6 billion was ra
IN VITRO DIAGNOSTICS Mergers & Acquisitions Alere Inc. eScreen Inc. Point-of-care diagnostics company Alere Inc. has acquired private drugs-of-abuse screening firm eScreen Inc. for $270mm in c